Center for Infectious Disease Dynamics, Departments of Biology and Entomology, The Pennsylvania State University, University Park, Pennsylvania, United States of America.
PLoS One. 2012;7(6):e37172. doi: 10.1371/journal.pone.0037172. Epub 2012 Jun 6.
The evolution of drug resistant Plasmodium parasites is a major challenge to effective malaria control. In theory, competitive interactions between sensitive parasites and resistant parasites within infections are a major determinant of the rate at which parasite evolution undermines drug efficacy. Competitive suppression of resistant parasites in untreated hosts slows the spread of resistance; competitive release following treatment enhances it. Here we report that for the murine model Plasmodium chabaudi, co-infection with drug-sensitive parasites can prevent the transmission of initially rare resistant parasites to mosquitoes. Removal of drug-sensitive parasites following chemotherapy enabled resistant parasites to transmit to mosquitoes as successfully as sensitive parasites in the absence of treatment. We also show that the genetic composition of gametocyte populations in host venous blood accurately reflects the genetic composition of gametocytes taken up by mosquitoes. Our data demonstrate that, at least for this mouse model, aggressive chemotherapy leads to very effective transmission of highly resistant parasites that are present in an infection, the very parasites which undermine the long term efficacy of front-line drugs.
耐药疟原虫的进化是有效疟疾控制的主要挑战。理论上,感染内敏感寄生虫和耐药寄生虫之间的竞争相互作用是寄生虫进化削弱药物疗效速度的主要决定因素。在未治疗的宿主中,耐药寄生虫的竞争抑制会减缓耐药性的传播;治疗后竞争释放会增强耐药性的传播。在这里,我们报告说,对于鼠模型疟原虫 chabaudi,与药物敏感寄生虫共同感染可以阻止最初罕见的耐药寄生虫传播给蚊子。在化疗后清除药物敏感寄生虫后,耐药寄生虫能够像在没有治疗的情况下那样成功地将其传播给蚊子。我们还表明,宿主静脉血液中配子体种群的遗传组成准确反映了被蚊子吸收的配子体的遗传组成。我们的数据表明,至少对于这种小鼠模型,积极的化疗会导致高度耐药寄生虫的非常有效的传播,这些寄生虫存在于感染中,正是这些寄生虫破坏了一线药物的长期疗效。